tetano
Editor, Senior Moderator
Geroscience
. 2023 Sep 27.
doi: 10.1007/s11357-023-00931-1. Online ahead of print. The effect of COVID-19 vaccination status on all-cause mortality in patients hospitalised with COVID-19 in Hungary during the delta wave of the pandemic
Viktor J Horvath[SUP] 1 [/SUP], Magdolna Békeffy[SUP] 2 [/SUP], Zsuzsanna Németh[SUP] 2 [/SUP], Emese Szelke[SUP] 2 [/SUP], Vince Fazekas-Pongor[SUP] 3 [/SUP], Noémi Hajdu[SUP] 2 [/SUP], Márk M Svébis[SUP] 2 [/SUP], József Pintér[SUP] 2 [/SUP], Beatrix A Domján[SUP] 2 [/SUP], Szilvia Mészáros[SUP] 2 [/SUP], Anna E Körei[SUP] 2 [/SUP], Árpád Kézdi[SUP] 2 [/SUP], Ibolya Kocsis[SUP] 4 [/SUP], Katalin Kristóf[SUP] 4 [/SUP], Péter Kempler[SUP] 2 [/SUP], Ferenc Rozgonyi[SUP] 4 [/SUP], István Takács[SUP] 2 [/SUP], Adam G Tabák[SUP] 2 3 5 [/SUP]
Affiliations
The high mortality of patients with coronavirus disease 2019 (COVID-19) is effectively reduced by vaccination. However, the effect of vaccination on mortality among hospitalised patients is under-researched. Thus, we investigated the effect of a full primary or an additional booster vaccination on in-hospital mortality among patients hospitalised with COVID-19 during the delta wave of the pandemic. This retrospective cohort included all patients (n = 430) admitted with COVID-19 at Semmelweis University Department of Medicine and Oncology in 01/OCT/2021-15/DEC/2021. Logistic regression models were built with COVID-19-associated in-hospital/30 day-mortality as outcome with hierarchical entry of predictors of vaccination, vaccination status, measures of disease severity, and chronic comorbidities. Deceased COVID-19 patients were older and presented more frequently with cardiac complications, chronic kidney disease, and active malignancy, as well as higher levels of inflammatory markers, serum creatinine, and lower albumin compared to surviving patients (all p < 0.05). However, the rates of vaccination were similar (52-55%) in both groups. Based on the fully adjusted model, there was a linear decrease of mortality from no/incomplete vaccination (ref) through full primary (OR 0.69, 95% CI: 0.39-1.23) to booster vaccination (OR 0.31, 95% CI 0.13-0.72, p = 0.006). Although unadjusted mortality was similar among vaccinated and unvaccinated patients, this was explained by differences in comorbidities and disease severity. In adjusted models, a full primary and especially a booster vaccination improved survival of patients hospitalised with COVID-19 during the delta wave of the pandemic. Our findings may improve the quality of patient provider discussions at the time of admission.
Keywords: COVID-19 disease; Hospitalisation; Mortality; Vaccination.
. 2023 Sep 27.
doi: 10.1007/s11357-023-00931-1. Online ahead of print. The effect of COVID-19 vaccination status on all-cause mortality in patients hospitalised with COVID-19 in Hungary during the delta wave of the pandemic
Viktor J Horvath[SUP] 1 [/SUP], Magdolna Békeffy[SUP] 2 [/SUP], Zsuzsanna Németh[SUP] 2 [/SUP], Emese Szelke[SUP] 2 [/SUP], Vince Fazekas-Pongor[SUP] 3 [/SUP], Noémi Hajdu[SUP] 2 [/SUP], Márk M Svébis[SUP] 2 [/SUP], József Pintér[SUP] 2 [/SUP], Beatrix A Domján[SUP] 2 [/SUP], Szilvia Mészáros[SUP] 2 [/SUP], Anna E Körei[SUP] 2 [/SUP], Árpád Kézdi[SUP] 2 [/SUP], Ibolya Kocsis[SUP] 4 [/SUP], Katalin Kristóf[SUP] 4 [/SUP], Péter Kempler[SUP] 2 [/SUP], Ferenc Rozgonyi[SUP] 4 [/SUP], István Takács[SUP] 2 [/SUP], Adam G Tabák[SUP] 2 3 5 [/SUP]
Affiliations
- PMID: 37755581
- DOI: 10.1007/s11357-023-00931-1
The high mortality of patients with coronavirus disease 2019 (COVID-19) is effectively reduced by vaccination. However, the effect of vaccination on mortality among hospitalised patients is under-researched. Thus, we investigated the effect of a full primary or an additional booster vaccination on in-hospital mortality among patients hospitalised with COVID-19 during the delta wave of the pandemic. This retrospective cohort included all patients (n = 430) admitted with COVID-19 at Semmelweis University Department of Medicine and Oncology in 01/OCT/2021-15/DEC/2021. Logistic regression models were built with COVID-19-associated in-hospital/30 day-mortality as outcome with hierarchical entry of predictors of vaccination, vaccination status, measures of disease severity, and chronic comorbidities. Deceased COVID-19 patients were older and presented more frequently with cardiac complications, chronic kidney disease, and active malignancy, as well as higher levels of inflammatory markers, serum creatinine, and lower albumin compared to surviving patients (all p < 0.05). However, the rates of vaccination were similar (52-55%) in both groups. Based on the fully adjusted model, there was a linear decrease of mortality from no/incomplete vaccination (ref) through full primary (OR 0.69, 95% CI: 0.39-1.23) to booster vaccination (OR 0.31, 95% CI 0.13-0.72, p = 0.006). Although unadjusted mortality was similar among vaccinated and unvaccinated patients, this was explained by differences in comorbidities and disease severity. In adjusted models, a full primary and especially a booster vaccination improved survival of patients hospitalised with COVID-19 during the delta wave of the pandemic. Our findings may improve the quality of patient provider discussions at the time of admission.
Keywords: COVID-19 disease; Hospitalisation; Mortality; Vaccination.